Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04023851
Other study ID # 01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 12, 2019
Est. completion date July 15, 2020

Study information

Verified date October 2020
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is intended to evaluate the impact of mobile application on management and knowledge acquisition in patients with epilepsy.


Description:

Investigators assess the general and personal knowledge of epilepsy, compliance of antiepileptic drugs (AED), and self efficacy scale. Participants be asked to use the mobile application (Brain4U) and record seizure type, frequency of seizures, aggravating factors, and adverse events related to antiepileptic drugs for 2 month period.


Recruitment information / eligibility

Status Completed
Enrollment 119
Est. completion date July 15, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 1 Year to 99 Years
Eligibility Inclusion Criteria: - Participants must be between the ages of 1-99. - Participants must attend Seoul National University Bundang Hospital Pediatric Neurology Outpatient Clinic. - Participants under age 18 must have an adult guardian give informed consent. - Participants must have a functioning smartphone (iOS or Android) which can download the and perform Brain4U application. - Participants must be able to use mobile application skillfully. Exclusion Criteria: - Person who does not have smartphone nor restricted to use mobile application can not participate this study. - Person with intellectual disability or unable to use mobile application can not participate this study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mobile application Brain4U
Brain4U application provides participants to record seizures, medications, side effects, and combined psychiatric problems. It also reminds participants when to take antiepileptic drugs.

Locations

Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of knowledge acquisition in epilepsy Baseline and 2 month Timepoint scores from questionnaires are assessed. Improvement in knowledge acquisition and self-efficacy by using questionnaire.
Genetal knowledge (G) Questionnaire:
There are total 10 questions (1 point score for each question) to evaluate general knowlege about epilepsy.
Score reported as (mean, SD), higher scores are better. Score ranges 0 to 10.
Persional knowledge (P) questionnaire:
There are total 4 questions (1 point score for each question) to evaluate knowlege about individual's epilepsy.
Score reported as (mean, SD), higher scores are better. Score ranges 0 to 4.
Self-efficacy scale (SE): There are 4 questions (1 point score for each question) to evaluate self-efficacy scale.
Score reported as (mean, SD), higher scores are better. Score ranges 0 to 4.
2 months
Secondary AED compliance Baseline and 2 month Timepoint AED compliances are reported.
Assess improvement of AED compliance by comparing "Days with AED per month" before and after using mobile application.
Count the "Days with AED" in a month and converted to the percentage.
Percentage ranges 0 to 100%. The high percentage means good compliance which means less AED skipping in a month.
2 months
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy N/A
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A